Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2020

May 28, 2020

60507_rns_2020-05-28_278ba4ec-1df7-4a3c-b15d-84d56533d1d0.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [63 x 37] intentionally omitted <==

Limited

The Capital, 1802 / 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

May 28, 2020

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd.[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sir/ Madam,

Sub: Pfizer Limited - Non-Applicability of Initial/Annual Disclosure to be made by an entity identified as a Large Corporate .

I, Prajeet Nair, Company Secretary of Pfizer Limited (“Company”) hereby confirm that, the Company has no borrowings as on March 31, 2020 and does not fall under the category of Large Corporate as per the SEBI circular dated November 26, 2018 bearing number SEBI/HO/DDHS/CIR/P/2018/144. Accordingly, the requirement for submission of Initial / Annual disclosure under the said Circular is not applicable to the Company.

We request you to kindly take the same on record.

Yours truly,

For PFIZER LIMITED

==> picture [118 x 59] intentionally omitted <==

Prajeet Nair Company Secretary

==> picture [11 x 21] intentionally omitted <==

CIN: L24231MH1950PLC008311